Sensitivity–Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration

Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD

(2020) John L Robinson et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia

(2019) Jennifer L. Whitwell et al.   NEUROLOGY

18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes

(2019) Richard M. Tsai et al.   Alzheimers Research & Therapy

Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site

(2019) Tetsuro Tago et al.   ANNALS OF NUCLEAR MEDICINE

Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease

(2019) Val J. Lowe et al.   Alzheimers & Dementia

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes

(2019) Clifford R Jack et al.   BRAIN

Tau-positron emission tomography correlates with neuropathology findings

(2019) Val J. Lowe et al.   Alzheimers & Dementia

[18 F]AV-1451 tau-PET and primary progressive aphasia

(2018) Keith A. Josephs et al.   ANNALS OF NEUROLOGY

Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech

(2018) Rene L. Utianski et al.   CORTEX

[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation

(2018) F. Ali et al.   JOURNAL OF NEUROLOGY

Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity

(2018) Siobhan Ewert et al.   NEUROIMAGE

Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy

(2018) Jennifer L. Whitwell et al.   PARKINSONISM & RELATED DISORDERS

Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

(2018) Renaud La Joie et al.   Alzheimers & Dementia

[ 18 F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia

(2017) W R Bevan-Jones et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

18 F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome

(2017) Hanna Cho et al.   NEUROLOGY

Regional correlations between [ 11 C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort

(2017) Sang Won Seo et al.   NeuroImage-Clinical

[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration

(2016) Keith A. Josephs et al.   ACTA NEUROPATHOLOGICA

Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration

(2016) Corey T. McMillan et al.   ACTA NEUROPATHOLOGICA

Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias

(2016) Kerstin Sander et al.   Alzheimers & Dementia

[18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy

(2016) Jennifer L. Whitwell et al.   MOVEMENT DISORDERS

Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy

(2016) Hanna Cho et al.   MOVEMENT DISORDERS

Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy

(2016) Ruben Smith et al.   MOVEMENT DISORDERS

An autoradiographic evaluation of AV-1451 Tau PET in dementia

(2016) Val J. Lowe et al.   Acta Neuropathologica Communications

Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue

(2015) Marta Marquié et al.   ANNALS OF NEUROLOGY

Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

(2015) Melissa E. Murray et al.   BRAIN

Primary age-related tauopathy (PART): a common pathology associated with human aging

(2014) John F. Crary et al.   ACTA NEUROPATHOLOGICA

Concomitant pathologies among a spectrum of parkinsonian disorders

(2014) Brittany N. Dugger et al.   PARKINSONISM & RELATED DISORDERS

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques

(2012) Ira Driscoll et al.   ACTA NEUROPATHOLOGICA

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

(2012) Bradley T. Hyman et al.   Alzheimers & Dementia

A harmonized classification system for FTLD-TDP pathology

(2011) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)

(2011) Dennis W. Dickson et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration?

(2010) J. L. Whitwell et al.   NEUROLOGY

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia

(2008) Marsel Mesulam et al.   ANNALS OF NEUROLOGY